45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
1,713
Insurances with rates
9
CPT / HCPCS codes
1,672
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J7330 | MACI FINAL PRODUCT ASSEMBLED | $104,504 | $52,252 | — | — | 10 |
| J9217 | leuprolide 45 mg/6 months Kit | $58,871 | $29,435 | — | — | 18 |
| J3380 | vedolizumab 300 mg Pow [UGH] | $44,928 | $22,464 | — | — | 36 |
| J2997 | alteplase 100 mg IV Inj [UGH] | $42,242 | $21,121 | — | — | 30 |
| J3101 | tenecteplase 25 mg Pow | $39,827 | $19,913 | — | — | 45 |
| C1822 | 1080-D IPG SENZA KIT | $38,550 | $19,275 | — | — | 13 |
| C1820 | SC-1216 PULSE GENERATOR KIT | $35,000 | $17,500 | — | — | 13 |
| C1767 | 3670 PROCLAIM PLUS 5 | $33,000 | $16,500 | — | — | 13 |
| J0775 | collagenase clostridium histolyticum 0.9 mg Pow | $31,605 | $15,803 | — | — | 18 |
| J2506 | pegfilgrastim 6 mg/0.6 ML SubQ Inj [UGH] | $25,960 | $12,980 | — | — | 18 |
| J2406 | oritavancin 1200 mg Pow | $25,617 | $12,809 | — | — | 36 |
| C1889 | ABS-1102-25 CARTIFORM 20 X 25MM DISC | $22,000 | $11,000 | — | — | 12 |
| J1930 | lanreotide 60 mg/0.2 ML Sol | $21,917 | $10,958 | — | — | 18 |
| J2323 | natalizumab 300 mg/15 ML IV Conc [UGH] | $21,187 | $10,594 | — | — | 18 |
| J1459 | immune globulin 10% IV Sol 200 ML [UGH] | $18,416 | $9,208 | — | — | 54 |
| J1162 | digoxin immune FAB 40 mg Inj [UGH] | $18,341 | $9,170 | — | — | 15 |
| C2622 | 720081-01 TACTRA 11MM X 16CM-25CM | $17,830 | $8,915 | — | — | 11 |
| J0256 | alpha 1-proteinase inhibitor human Pow | $17,244 | $8,622 | — | — | 18 |
| J1306 | inclisiran 284 mg/1.5 ML Sol | $17,221 | $8,611 | — | — | 36 |
| Q5119 | riTUXimab pvvr 10 mg/ML Sol | $17,203 | $8,602 | — | — | 18 |
| J1437 | ferric derisomaltose 100 mg/ML Sol | $16,200 | $8,100 | — | — | 36 |
| j3101 | tenecteplase 50 mg IV Inj [UGH] | $15,392 | $7,696 | — | — | 60 |
| J0840 | antivenin (Crotalidae) polyvalent - Pow [UGH] | $15,350 | $7,675 | — | — | 15 |
| J2182 | mepolizumab 100 mg/ML Sol | $14,756 | $7,378 | — | — | 18 |
| J0717 | certolizumab 200 mg/ML Kit [UGH] | $14,716 | $7,358 | — | — | 15 |
| J1561 | immune globulin 10% IV Sol 200ML [UGH] | $14,280 | $7,140 | — | — | 36 |
| Q4128 | FLEXHD PERF LRG PLIABLE SHAPED 13X22 | $13,820 | $6,910 | — | — | 18 |
| J0597 | C1 esterase inhibitor, human 500 intl units Kit [UGH] | $13,512 | $6,756 | — | — | 15 |
| J1951 | leuprolide 45 mg/6 months PWD | $13,009 | $6,504 | — | — | 18 |
| 25400 | 25400 Repair radius or ulna | $12,162 | $6,081 | — | — | 16 |
| J3111 | romosozumab 105 mg/1.17 ML Sol | $12,018 | $6,009 | — | — | 108 |
| C1786 | PACER ADVISA SR MRI SURESCAN SINGLE | $11,160 | $5,580 | — | — | 13 |
| J0881 | darbepoetin alfa 300 mcg/0.6 ML Inj Sol [UGH] | $11,148 | $5,574 | — | — | 18 |
| C1764 | ASSERT IQ 3+ | $10,200 | $5,100 | — | — | 13 |
| Q0222 | bebtelovimab 175 mg/2 ML Sol | $10,080 | $5,040 | — | — | 10 |
| J3358 | ustekinumab 5 mg/ML Sol | $9,718 | $4,859 | — | — | 18 |
| J1602 | golimumab 50 mg/4 ML Sol [UGH] | $9,596 | $4,798 | — | — | 54 |
| J0897 | denosumab 60 mg/ML Sol | $9,002 | $4,501 | — | — | 54 |
| J0630 | calcitonin 200 intl units/ML Inj Sol [UGH] | $8,673 | $4,337 | — | — | 78 |
| J1451 | fomepizole 1 g/ML Sol | $8,312 | $4,156 | — | — | 30 |
| Q4125 | DECELLULARIZED DERMIS 40 X 70 | $7,931 | $3,966 | — | — | 18 |
| C2621 | PACEMAKER GENERATOR IPG SENSIA | $7,800 | $3,900 | — | — | 13 |
| Q5136 | denosumab bbdz 60 mg/ML Sol | $7,700 | $3,850 | — | — | 18 |
| C1763 | BBRC-23 BIOBRACE 23 X 25 | $7,400 | $3,700 | — | — | 12 |
| V2790 | AVIVE SOFT TISSUE MEMBRANE | $7,380 | $3,690 | — | — | 13 |
| J1439 | ferric carboxymaltose (as elemental iron) 50 mg/ML Sol | $7,363 | $3,681 | — | — | 54 |
| C1734 | 45647012 OSTEOCHONDRAL CORE FS/A 12MM | $7,200 | $3,600 | — | — | 12 |
| J7325 | hylan G-F 20 48 mg/6 ML Sol | $6,574 | $3,287 | — | — | 30 |
| J9280 | mitoMYcin 40 mg Pow | $6,573 | $3,286 | — | — | 54 |
| J3262 | tocilizumab 200 mg/10 ML Sol [UGH] | $6,374 | $3,187 | — | — | 54 |
Showing top 50 of 1,713 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.